Weekly Digest – April 2025 Weekly Digest – April 2025 10 Apr 2025: IDEAYA Biosciences announces Phase 1/2 expansion for IDE397 and Trodelvy combination in MTAP-deletion urothelial cancer IDEAYA Biosciences has begun a Phase 1/2 trial of a MAT2A inhibitor, […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id